🇺🇸 FDA
Patent

US 7892569

Methods of altering an immune response induced by CpG oligodeoxynucleotides

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7892569 (Methods of altering an immune response induced by CpG oligodeoxynucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/02, A61P11/04